Coronavirus vaccine from Moderna in first human trial showed promising early signs that it can create an immune-system response in the body that could help fend off the Covid-19 NEW YORK : An experimental vaccine from Moderna Inc.
showed promising early signs that it can create an immune-system response in the body that could help fend off the new coronavirus, according to sampling of data from a small, first human trial of the inoculation.
The study was primarily designed to look at the safety of the shot and showed no major warning signs in a small phase 1 trial, the company said in a statement Monday.
The trial is being run with the US government, and Moderna plans to continue advancing it to wider testing. A vaccine is considered a